VBD(vertebrobasilar dolichoectasia)
Conditions
Interventions
Observation group:None
Sponsors
Renmin Hospital of Wuhan University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Aged >=18 years (male or female); 2. Diagnosed with Vertebrobasilar Dolichoectasia (VBD) via DSA, CTA, or MRA; 3. Patients and/or authorized representatives understand the study purpose, voluntarily participate, and sign informed consent forms; 4. Scheduled for treatment with domestically manufactured flow-diverting devices after evaluation by =2 experienced clinicians; 5. Willing and able to complete all protocol-required follow-ups.
Exclusion criteria
Exclusion criteria: 1.The lesion has undergone treatment with coil embolization or stent-assisted coil embolization within the past 90 days; 2.Patients who have undergone or are scheduled to undergo major surgery within 30 days; 3.Arteriovenous malformation (AVM)-related aneurysms; 4. Patients with incomplete follow-up or imaging data; 5.Participation in other clinical trials; 6. Life expectancy of less than 12 months; 7.Women who are pregnant, breastfeeding, or planning to become pregnant during the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete occlusion rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Modified Rankin Scale (mRS);Success rate of stent-implantation;Disability rate;Re-treatment rate;Postoperative Drug Regimen;in-stent restenosis;Neurological mortality rate;All-cause mortality; | — |
Countries
China
Contacts
Public ContactMingchang Li
Renmin Hospital of Wuhan University
Outcome results
None listed